Recognizing that precise definition of medicinal products and drugs are to be found in the laws, regulations and administrative provisions referred to in Appendix 1, an indicative list of products covered by the Annex is given below. This applies to processing, packaging, testing and sterilizing facilities, including contract facilities performing these functions.
Marketed finished pharmaceuticals for human use in various pharmaceutical dosage forms such as tablets, capsules, ointments, and injectables, including:
Medical gases;
Radiopharmaceuticals or radioactive biological products;
Herbal (botanical) products [These are included to the extent that they are regulated as drugs by the FDA and medicinal products by the EU.]; and
Homeopathic products;
Marketed biological products:
Vaccines for human use [These products are only included within the product coverage of this Annex to the extent the Joint Sectoral Committee decides to include them pursuant to Article 20.];
Plasma derived pharmaceuticals [These products are only included within the product coverage of this Annex to the extent the Joint Sectoral Committee decides to include them pursuant to Article 20.];
Therapeutic biotechnology-derived biological products; and
Allergenic products.
In process materials (for the United States as defined under U.S. law) and intermediates (for the European Union as defined in EU legislation);
Active pharmaceutical ingredients or bulk drug substance;
Investigational products (clinical trial material) [The FDA does not routinely conduct GMP inspections for investigational medicinal products. Inspection information on these products will be provided to the extent that they are available and resources allow. These products are only included within the product coverage of this Annex to the extent the Joint Sectoral Committee decides to include them.]; and
Veterinary products [These products are only included within the product coverage of this Annex to the extent the Joint Sectoral Committee decides to include them pursuant to Article 20.]:
veterinary pharmaceuticals, including prescription and non-prescription drugs, with the exclusion of veterinary immunologicals;
pre-mixes for the preparation of veterinary medicated feeds (EU), Type A medicated articles for the preparation of veterinary medicated feeds (US);